Clari Vest Asset Management LLC Editas Medicine, Inc. Transaction History

Clari Vest Asset Management LLC

  • $1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$12.16 - $19.42 $948 - $1,514
-78 Reduced 0.27%
28,417 $348,000
Q2 2022

Aug 12, 2022
BUY
$9.99 - $21.35 $99,880 - $213,457
9,998 Added 54.05%
28,495 $337,000
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $202,178 - $308,940
7,615 Added 69.98%
18,497 $491,000
Q3 2021

Nov 08, 2021
BUY
$39.27 - $72.94 $427,336 - $793,733
10,882 New
10,882 $447,000

Others Institutions Holding EDIT

# of Institutions
244
Shares Held
56.8M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email